Jun Teishima

Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition

Engineering precision nanoparticles for drug delivery

Oxidative stress, inflammation, and cancer: How are they linked?

Advances and challenges in targeting FGFR signalling in cancer

Integrins in cancer: biological implications and therapeutic opportunities

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 Integrins

CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro

Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate

The complexity of NF-κB signaling in inflammation and cancer

Underlying mechanisms and drug intervention strategies for the tumour microenvironment

Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells

Inflammation and tumor progression: signaling pathways and targeted intervention

Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer

Bladder cancer

Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy

Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder

Overexpression of FGF9 in colon cancer cells is mediated by hypoxia-induced translational activation

CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro

Chemokine receptor expression on integrin-mediated stellate projections of prostate cancer cells in 3D culture

Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

Inflammation and cancer: how friendly is the relationship for cancer patients?

Associations of lower urinary tract symptoms with prostate‐specific antigen levels, and screen‐detected localized and advanced prostate cancer: a case‐control study nested within the UK population‐based ProtecT (Prostate testing for cancer and Treatment) study

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

The Fibroblast Growth Factor signaling pathway

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression

40 YEARS OF IGF1: IGF-binding proteins

The Impact of Squamous and Glandular Differentiation on Survival After Radical Cystectomy for Urothelial Carcinoma

Combination therapy in combating cancer

Targeting Tumor Microenvironment for Cancer Therapy

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation

Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer

Bisphosphonates for advanced prostate cancer

A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial

Lower urinary tract symptoms and risk of prostate cancer in Japanese men

The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation

Relationship between the localization of fibroblast growth factor 9 in prostate cancer cells and postoperative recurrence

Interaction of ligand–receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis

Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma

Transrectal ultrasound-guided 10-core biopsy of the prostate for Japanese patients.

A phase III, multicenter, randomized, controlled study of maximum androgen blockade with versus without zoledronic acid in treatment-naïve prostate cancer patients with bone metastases: Results of ZAPCA study.

Combination therapy using molecular‐targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma

FGF19 promotes progression of prostate cancer